A 69-Year-Old Man With Advanced Castrate-Resistant Prostate Cancer

Video

Jorge Garcia, MD, FACP, provides insight on the case of a 69-year-old man with mCRPC and assesses the classes of agents currently available as treatment options.

Case:A 69-Year-Old Man with Advanced Castrate Resistant Prostate Cancer

Initial presentation

  • A 69-year-old man presented with intermittent back discomfort and loss of appetite
  • PMH: hyperlipidemia controlled on a statin, no known family history of cancer
  • PE: DRE revealed asymmetric, boggy prostate; otherwise unremarkable

Clinical Workup

  • Biopsy with TRUS showed adenocarcinoma of prostate
    • Stage T2N0M0
    • Grade group 4
  • Germline genetic testing: MLH1, MSH2, MSH6, PMS2, BRCA1/2, ATM, PALB2 and CHEK2
  • Chest/abdominal/pelvic CT scan showed no evidence distant metastases or lymph node involvement
  • Bone scan was negative
  • PSA 24.9 ng/mL

Treatment and Follow-Up

  • EBRT + ADT was started
  • Follow up at 6 months, PSA 11.2 ng/mL
  • At 12 months PSA 18.6 ng/mL
    • Patient reported increasing back discomfort and difficulty walking
    • Bone scan at that time showed multiple vertebral lesions at L3/L4
  • Treatment with radium-223 dichloride was initiate
    • 6 infusions were completed, treatment was well tolerated
Related Videos
Stephen T. Oh, MD, PhD, an expert on myelofibrosis
Stephen T. Oh, MD, PhD, an expert on myelofibrosis
Stephen T. Oh, MD, PhD, an expert on myelofibrosis
Stephen T. Oh, MD, PhD, an expert on myelofibrosis
Stephen T. Oh, MD, PhD, an expert on myelofibrosis
Stephen T. Oh, MD, PhD, an expert on myelofibrosis
Stephen T. Oh, MD, PhD, an expert on myelofibrosis
Stephen T. Oh, MD, PhD, an expert on myelofibrosis
Related Content